BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1227 related articles for article (PubMed ID: 16011870)

  • 1. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain barrier: an overview: structure, regulation, and clinical implications.
    Ballabh P; Braun A; Nedergaard M
    Neurobiol Dis; 2004 Jun; 16(1):1-13. PubMed ID: 15207256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in brain penetration evaluation in drug discovery and development.
    Liu X; Chen C; Smith BJ
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J; Skjørringe T; Thomsen LB; Moos T
    J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transporter-mediated uptake into cellular compartments.
    Oswald S; Grube M; Siegmund W; Kroemer HK
    Xenobiotica; 2007; 37(10-11):1171-95. PubMed ID: 17968742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
    Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges for blood-brain barrier (BBB) screening.
    Jeffrey P; Summerfield SG
    Xenobiotica; 2007; 37(10-11):1135-51. PubMed ID: 17968740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier efflux transport.
    Golden PL; Pollack GM
    J Pharm Sci; 2003 Sep; 92(9):1739-53. PubMed ID: 12949994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress.
    Spector R
    J Neurochem; 2010 Jan; 112(1):13-23. PubMed ID: 19860860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
    Lee G; Dallas S; Hong M; Bendayan R
    Pharmacol Rev; 2001 Dec; 53(4):569-96. PubMed ID: 11734619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins.
    Akanuma S; Hosoya K; Ito S; Tachikawa M; Terasaki T; Ohtsuki S
    J Pharmacol Exp Ther; 2010 Jun; 333(3):912-9. PubMed ID: 20194529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].
    Jacob A; Declèves X; Scherrmann JM
    Biol Aujourdhui; 2012; 206(3):177-83. PubMed ID: 23171840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in brain diseases and the role of drug efflux transporters.
    Löscher W; Potschka H
    Nat Rev Neurosci; 2005 Aug; 6(8):591-602. PubMed ID: 16025095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confocal imaging of xenobiotic transport across the blood-brain barrier.
    Miller DS
    J Exp Zool A Comp Exp Biol; 2003 Nov; 300(1):84-90. PubMed ID: 14598390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.